Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome M Koziróg, AR Poliwczak, P Duchnowicz, M Koter‐Michalak, J Sikora, ... Journal of pineal research 50 (3), 261-266, 2011 | 388 | 2011 |
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial J Kubica, P Adamski, M Ostrowska, J Sikora, JM Kubica, WD Sroka, ... European heart journal 37 (3), 245-252, 2016 | 321 | 2016 |
Metformin–A future therapy for neurodegenerative diseases: Theme: Drug discovery, development and delivery in Alzheimer's disease Guest Editor: Davide Brambilla M Markowicz-Piasecka, J Sikora, A Szydłowska, A Skupień, ... Pharmaceutical research 34, 2614-2627, 2017 | 249 | 2017 |
Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker levels in patients with metabolic syndrome M Broncel1ABDEFG, M Koziróg1ABDEF, P Duchnowicz2ABD, ... Med Sci Monit 16 (1), 34, 2010 | 190 | 2010 |
Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics M Markowicz-Piasecka, K M Huttunen, L Mateusiak, E Mikiciuk-Olasik, ... Current pharmaceutical design 23 (17), 2532-2550, 2017 | 114 | 2017 |
Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome J Sikora, M Broncel, M Markowicz, M Chałubiński, K Wojdan, ... European Journal of Nutrition 51, 549-556, 2012 | 97 | 2012 |
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology U Zeymer, P Ludman, N Danchin, P Kala, C Laroche, M Sadeghi, ... European heart journal 42 (44), 4536-4549, 2021 | 58 | 2021 |
Effect of statins on platelet function in patients with hyperlipidemia J Sikora, B Kostka, I Marczyk, U Krajewska, M Chałubiński, M Broncel Archives of Medical Science 9 (4), 622-628, 2013 | 57 | 2013 |
Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery M Podsiedlik, M Markowicz-Piasecka, J Sikora Chemico-Biological Interactions 332, 109305, 2020 | 53 | 2020 |
METoclopramide administration as a strategy to overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS—the METAMORPHOSIS trial J Sikora, P Niezgoda, M Barańska, K Buszko, N Skibińska, W Sroka, ... Thrombosis and haemostasis 118 (12), 2126-2133, 2018 | 52 | 2018 |
Extract of Aronia melanocarpa-modified hemostasis: in vitro studies J Sikora, M Markowicz-Piasecka, M Broncel, E Mikiciuk-Olasik European journal of nutrition 53, 1493-1502, 2014 | 48 | 2014 |
Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina P Niezgoda, J Sikora, M Barańska, A Sikora, K Buszko, E Siemińska, ... Thrombosis and Haemostasis 117 (04), 718-726, 2017 | 45 | 2017 |
Synaptic zinc: an emerging player in Parkinson’s disease J Sikora, AM Ouagazzal International journal of molecular sciences 22 (9), 4724, 2021 | 39 | 2021 |
Aronia melanocarpa Elliot reduces the activity of angiotensin I-converting enzyme—in vitro and ex vivo studies J Sikora, M Broncel, E Mikiciuk-Olasik Oxidative Medicine and Cellular Longevity 2014, 2014 | 39 | 2014 |
Studies towards biocompatibility of PAMAM dendrimers–overall hemostasis potential and integrity of the human aortic endothelial barrier M Markowicz-Piasecka, E Łuczak, M Chałubiński, M Broncel, ... International Journal of Pharmaceutics 473 (1-2), 158-169, 2014 | 37 | 2014 |
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A … P Adamski, J Sikora, E Laskowska, K Buszko, M Ostrowska, JM Umińska, ... PLoS One 12 (10), e0186013, 2017 | 33 | 2017 |
Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease M Bajda, J Jończyk, B Malawska, K Czarnecka, M Girek, P Olszewska, ... Bioorganic & Medicinal Chemistry 23 (17), 5610-5618, 2015 | 33 | 2015 |
Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled … J Kubica, P Adamski, K Buszko, M Barańska, J Sikora, MP Marszałł, ... European Heart Journal-Cardiovascular Pharmacotherapy 5 (3), 139-148, 2019 | 32 | 2019 |
Metabolism of ticagrelor in patients with acute coronary syndromes P Adamski, K Buszko, J Sikora, P Niezgoda, M Barańska, M Ostrowska, ... Scientific reports 8 (1), 11746, 2018 | 32 | 2018 |
Metformin and its sulfenamide prodrugs inhibit human cholinesterase activity M Markowicz-Piasecka, J Sikora, Ł Mateusiak, E Mikiciuk-Olasik, ... Oxidative Medicine and Cellular Longevity 2017, 2017 | 32 | 2017 |